Yahoo Web Search

Search results

    • Gateway - Quartz

      Quartz· 4 days ago

      After dominating the market for weight loss drugs, Ozempic maker Novo Nordisk has set its sights on tackling treatments for heart disease next. Cardior, ...

    • Gateway - Quartz

      Quartz· 4 days ago

      Novo Nordisk is making moves to prevent the misuse of semaglutide. The Danish company has filed several lawsuits in the US against certain medical spas, weight loss ...